Roivant Sciences (ROIV)
NASDAQ:ROIV
Holding ROIV?
Track your performance easily

Roivant Sciences (ROIV) Financial Statements

574 Followers

Roivant Sciences Financial Overview

Roivant Sciences's market cap is currently ―. The company's EPS TTM is $5.655; its P/E ratio is 1.98; Roivant Sciences is scheduled to report earnings on February 17, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 4.47M$ 55.13M$ 28.93M$ 37.14M$ 37.10M
Gross Profit$ 4.47M$ 55.13M$ 24.52M$ 33.47M$ 33.84M
EBIT$ -224.38M$ -213.19M$ -184.28M$ 5.11B$ -318.11M
EBITDA$ -217.96M$ -206.73M$ -179.05M$ 5.11B$ -312.53M
Net Income Common Stockholders$ -230.18M$ 95.30M$ -151.12M$ 5.10B$ -304.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.39B$ 5.68B$ 6.54B$ 6.67B$ 1.41B
Total Assets$ 6.21B$ 6.50B$ 7.22B$ 7.31B$ 2.07B
Total Debt$ 52.71M$ 379.06M$ 499.75M$ 506.58M$ 497.98M
Net Debt$ -5.33B$ -5.30B$ -6.04B$ -6.16B$ -910.25M
Total Liabilities$ 625.99M$ 601.16M$ 773.95M$ 728.10M$ 739.91M
Stockholders Equity$ 5.15B$ 5.44B$ 5.97B$ 6.09B$ 948.53M
Cash Flow-
Free Cash Flow$ -267.80M$ -193.79M$ -108.81M$ -210.81M$ -196.70M
Operating Cash Flow$ -266.81M$ -192.83M$ -108.46M$ -210.45M$ -196.43M
Investing Cash Flow$ -3.29B$ -965.00K$ 6.93M$ 5.23B$ -36.45M
Financing Cash Flow$ -109.07M$ -660.62M$ -32.62M$ 236.64M$ 207.87M
Currency in USD

Roivant Sciences Earnings and Revenue History

Roivant Sciences Debt to Assets

Roivant Sciences Cash Flow

Roivant Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis